Apologies for bringing up a post which is already surpassed in the queue by 350 - But I'm pretty sure the reason's are per this above post in that they are the Countries who are at the forefront of the COVID-19 in terms of the WHO and World Health collaborations .....and clearly have more money available to them for the required higher levels of ' Funding ' . So why NOT handball the process over to them . They have far more expertise than that which would be available here in Australia I would think. Even the University of QLD only got $5 million disbursed from this Global Organisation for it's potential COVID-19 Vaccine initiative. So I reckon it's a very good move.
Ann: PAA Evaluate MPL Suitability for Ex-Vivo Human COVID-19 Test, page-97
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.5¢ |
Change
0.030(16.2%) |
Mkt cap ! $79.18M | |||
| Open | High | Low | Value | Volume |
| 20.5¢ | 21.5¢ | 20.0¢ | $533.2K | 2.596M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 78494 | 21.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.5¢ | 193065 | 4 |
View Market Depth
| Last trade - 12.25pm 31/05/2024 (20 minute delay) ? |
|
|||||
|
Last
21.5¢ |
Change
0.030 ( 16.2 %) |
||||
| Open | High | Low | Volume | ||
| 20.5¢ | 21.5¢ | 20.0¢ | 862334 | ||
| Last updated 12.52pm 31/05/2024 ? | |||||
| PAA (ASX) Chart |